Produkty 86377-52-8

CAS 86377-52-8 występuje w naszej ofercie pod nazwami: Ganoderic acid Y, Ganoderic acid Y, (3β,24E)-3-Hydroxylanosta-7,9(11),24-trien-26-oic acid, 99.07%, 99.07%, Ganoderic acid Y, 99.32%. Oferty producentów: GLPBio, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 10mg, 5mg, 25mg, 50mg, 1 mg.

Ganoderic acid Y
GLPBio
  • opakowanie: 1mg
  • Warianty: 1
od 2941,97
Zobacz produkt
Ganoderic acid Y
Biosynth
  • opakowanie: 10mg, 5mg, 25mg, 50mg
  • Warianty: 4
Zobacz produkt
(3β,24E)-3-Hydroxylanosta-7,9(11),24-trien-26-oic acid, 99.07%, 99.07%
Chemat
  • opakowanie: 1mg
  • Warianty: 1
od 6414,80
Zobacz produkt
Ganoderic acid Y, 99.32%
MedChemExpress
  • opakowanie: 1 mg
  • Warianty: 1
od 2999,28
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(E,6R)-6-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid (CAS 86377-52-8) to związek chemiczny o wzorze sumarycznym C30H46O3 i masie molowej 454.7 g/mol. Nazwa systematyczna IUPAC: (E,6R)-6-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid. InChIKey: HUTCYUJPLOTDMX-SPPZYOJVSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H46O3
Masa molowa454.7 g/mol
Nazwa IUPAC(E,6R)-6-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid
InChIKeyHUTCYUJPLOTDMX-SPPZYOJVSA-N
SMILESC[C@H](CC/C=C(\C)/C(=O)O)[C@H]1CC[C@@]2([C@@]1(CC=C3C2=CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Ganoderic Acid Y, (3beta,24E)-3-Hydroxylanosta-7,9(11),24-trien-26-oic acid, orb1684587, (24E)-3beta-Hydroxylanosta-7,9(11),24-trien-26-oic acid, (3|A,24E)-3-Hydroxylanosta-7,9(11),24-trien-26-oic acid, Lanosta-7,9(11),24-trien-26-oic acid, 3-hydroxy-, (3|A,24E)-
Powiązane formy tego związku
(E,6R)-6-[(3R,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid C30H46O3
Izomery (ten sam wzór sumaryczny)
(1S,2R,5S,6R,9R,11S,14R,15R,19S,21S)-11-hydroxy-2,5,6,10,10,14,21-heptamethyl-23-oxahexacyclo[19.2.1.02,19.05,18.06,15.09,14]tetracos-17-en-22-one C30H46O3
(4aS,6aR,6aR,6bR,8aR,12aR,14aS)-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-4,5,6,6a,7,8,8a,11,12,13,14,14a-dodecahydro-3H-picene-4a-carboxylic acid C30H46O3
[(8S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] undecanoate C30H46O3
(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-9-oxo-1-prop-1-en-2-yl-2,3,4,5,6,7,7a,10,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid C30H46O3
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] undecanoate C30H46O3
(1R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,6a,6b,9,9,12a-hexamethyl-2-methylidene-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid C30H46O3
(4aS,6aR,6aS,6bR,8aR,12aR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid C30H46O3
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12-dodecahydropicene-2-carboxylic acid C30H46O3
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] undecanoate C30H46O3
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undec-10-enoate C30H46O3
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 4-butylcyclohexane-1-carboxylate C30H46O3